lunes, 14 de septiembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· March 2, 2026

Zefiro Founder and Former Chairman Reports Initial Success in New York Litigation

View original at globenewswire.com
Zefiro Founder and Former Chairman Reports Initial Success in New York Litigation TORONTO, March 02, 2026 (GLOBE NEWSWIRE) -- Dr. Talal A. Debs, Founder and Director of Zefiro Methane Corp…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Board has not provided update on investigation findings more than four months after announcement

    80% confidence
  • The NY Litigation was used by incumbent directors as pretext for frivolous investigation into Dr. Debs at considerable expense to shareholders

    80% confidence
  • Incumbent directors took bad faith steps to entrench themselves, including issuing debt settlement shares to allies immediately before meeting record date

    80% confidence
  • Company referenced ongoing investigation as reason not to support Concerned Shareholders' director nominees

    80% confidence
  • McGrath's litigation is part of broader attempt to wrest control of XMC and XMST from Dr. Debs

    80% confidence
  • Special committee investigation scrutinized approximately $30,000 of expenses, with only one claim under $600 remaining in question

    80% confidence
  • Investigation found no material improprieties despite consuming meaningful cash resources

    80% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
Señalamos los conflictos abiertamente ›
Verificado recientemente
Verificado con la fuente original
4,981
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,981 hechos verificados con la fuente5,285 documentos fuente archivados
Consulta estos datos → isubstrate.com